VEGF antagonist formulations suitable for intravitreal administration | Patent Number 11084865

US 11084865 B2
Application Number16739559
Publication NumberUS 20200131246 A1
Pendency1 year, 7 months, 3 days
Filled DateJan 10, 2020
Priority DateJun 16, 2006
Publication DateApr 30, 2020
Expiration DateJun 15, 2026
Inventor/ApplicantsDaniel Dix
Kenneth Graham
Kelly Frye
Eric Furfine
Eric FURFINE
Kelly FRYE
Kenneth GRAHAM
Daniel DIX
ExaminesLOCKARD, JON MCCLELLAND
Art Unit1647
Technology Center1600
Assignments
Regeneron Pharmaceuticals
Current
Regeneron Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.